Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStandard

EPINEPHRINE

EPINEPHRINE

Standard Dose
1MG/ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview EPINEPHRINE is listed in Drugs@FDA under application 205029 (NDA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 1MG/ML (1MG/ML) Sponsor BPI LABS Submission history Latest submission status date: 2025-06-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPINEPHRINE is listed in Drugs@FDA under application 205029 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 1MG/ML (1MG/ML) Sponsor BPI LABS Submission history Latest submission status date: 2025-06-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.